Success Story: In Just 17 Days, A Chinese Senior Scientist Received O1A Approval with the help of NAILG’s teamwork and Direct Premium Service
Client’s Testimonial:
“Thank you so much, my attorney and Wegreened! I truly appreciate all your time and effort in expediting my application. I would really love to recommend you to all the people who ever need any immigrant help.”
On June 28th, 2025, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Senior Scientist in the Field of Biotherapeutics (Approval Notice).
General Field: Biotherapeutics
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: June 28th, 2025
Processing Time: 17 days (Premium Processing Requested)
Case Summary:
We are thrilled to share the successful outcome of an O1-A petition filed by North America Immigration Law Group (NAILG) on behalf of a talented biotherapeutics researcher specializing in the structural biology of proteins and ribonucleic acids (RNAs). Holding a Ph.D. in biochemistry and biophysics, our client is currently employed as a senior scientist in the United States and has made original contributions to the advancement of antibody discovery and high-pressure biomolecular research. This case was filed with direct premium processing and approved in just 17 days, highlighting the strength and clarity of the petition.
Revolutionizing Protein and RNA Structural Biology
Our client’s scientific journey has focused on leveraging high-pressure techniques to reveal structural dynamics in proteins and RNAs, critical molecules involved in numerous physiological processes and therapeutic targets. Her research utilizes advanced tools like high-pressure small-angle X-ray scattering (HP-SAXS) and high-resolution nuclear magnetic resonance (NMR) spectroscopy to elucidate mechanisms of protein folding and RNA conformational changes under stress conditions. These efforts have paved the way for breakthroughs in therapeutic protein design, the understanding of disease-related molecular mechanisms, and improvements in antibody screening and characterization workflows.
Recognized Contributions and Global Impact
NAILG structured the petition to highlight the major significance of our client’s research. We provided concrete evidence of her accomplishments and their broad scientific influence, including:
● 5 peer-reviewed journal articles and 10 scientific abstracts
● 36 citations by independent researchers from globally respected institutions
● At least 5 formal peer reviews for reputable journals in her field
● Research funded by premier institutions, including the National Science Foundation (NSF), National Institutes of Health (NIH), NASA, and several top European scientific agencies
Endorsements from Distinguished Experts
The petition included four compelling recommendation letters from leading scientists, including two independent advisory opinions. These letters spoke to the originality, impact, and critical importance of the client’s work in biotherapeutics. One expert noted:
“Thus, [Client’s] record of achievement amply demonstrates the indispensability of her research to the United States.”
Strategic Preparation Yields Swift O1A Approval
This robust submission resulted in an RFE-free approval just 17 days after filing under direct premium processing. We proudly celebrate this success and remain confident that our client will continue to advance the field of biotherapeutics and biomedical innovation in the United States. NAILG is honored to have supported her in achieving this important immigration milestone.